FDA Approves SOMA® (carisoprodol) 250 mg Product in the US
- [September, 2007]

Meda acquires exclusive rights to potential specialty blockbuster product in the US
- [September, 2007]

Strategic Acquisition of MedPointe Inc completed
- [August, 2007]

Meda enters the US market through the strategic acquisition of MedPointe Inc
- [July, 2007]

MedPointe Pharmaceuticals Announces the Appointment of John J.Howarth to Vice President of Public Affairs and Investor Relations
- [May, 2007]

MedPointe Settles Litigation with Hi-Tech and Successfully Enforces Patent Covering Its Tussi-12® D Products
- [May, 2007]

Steroid-Free Astelin® Nasal Spray Demonstrated Seasonal Allergy Symptom Improvement Within 15 Minutes in Clinical Study
- [February, 2007]

Further inquiries should be directed to info@medapharma.us